Engineering dendritic cell vaccines to improve cancer immunotherapy

被引：0
|
作者：
Caleb R. Perez
Michele De Palma
机构：
[1] École Polytechnique Fédérale de Lausanne (EPFL),Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences
来源：
Nature Communications | / 10卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
At the interface between the innate and adaptive immune system, dendritic cells (DCs) play key roles in tumour immunity and hold a hitherto unrealized potential for cancer immunotherapy. Here we review the role of distinct DC subsets in the tumour microenvironment, with special emphasis on conventional type 1 DCs. Integrating new knowledge of DC biology and advancements in cell engineering, we provide a blueprint for the rational design of optimized DC vaccines for personalized cancer medicine.
引用
收藏
相关论文
共 50 条
  • [41] Engineering Dendritic Cells to Enhance Cancer Immunotherapy
    Boudreau, Jeanette E.
    Bonehill, Aude
    Thielemans, Kris
    Wan, Yonghong
    MOLECULAR THERAPY, 2011, 19 (05) : 841 - 853
  • [42] Engineering dendritic cell-based vaccines as targeted immunotherapy against medulloblastoma, neuroblastoma, and Ewing sarcoma
    Zahler, Stacey
    Luo, Wen
    Ayello, Janet
    Cairo, Mitchell S.
    CANCER RESEARCH, 2016, 76
  • [43] Dendritic Cell Vaccines in Ovarian Cancer
    Zhang, Xi
    He, Tianhui
    Li, Yuan
    Chen, Ling
    Liu, Hongyu
    Wu, Yu
    Guo, Hongyan
    FRONTIERS IN IMMUNOLOGY, 2021, 11
  • [44] The dendritic cell and human cancer vaccines
    Dallal, RM
    Lotze, MT
    CURRENT OPINION IN IMMUNOLOGY, 2000, 12 (05) : 583 - 588
  • [45] Dendritic cell vaccines for cancer treatment
    Gabrilovich, DI
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2002, 4 (05) : 452 - 458
  • [46] Dendritic cell vaccines for cancer therapy
    Sprinzl, GM
    Kacani, L
    Schrott-Fischer, A
    Romani, N
    Thumfart, WF
    CANCER TREATMENT REVIEWS, 2001, 27 (04) : 247 - 255
  • [47] Exploiting a new strategy to induce immunogenic cell death to improve dendritic cell-based vaccines for lymphoma immunotherapy
    Montico, B.
    Lapenta, C.
    Ravo, M.
    Martorelli, D.
    Muraro, E.
    Zeng, B.
    Comaro, E.
    Spada, M.
    Donati, S.
    Santini, S. M.
    Tarallo, R.
    Giurato, G.
    Rizzo, F.
    Weisz, A.
    Belardelli, F.
    Dolcetti, R.
    Dal Col, J.
    ONCOIMMUNOLOGY, 2017, 6 (11):
  • [48] Modeling of dendritic cell vaccines for ovarian cancer immunotherapy using cell lines of different molecular profiles
    Mlynska, Agata
    Zymantaite, Egle
    Paberale, Emilija
    Krasko, Jan Aleksander
    Pasukoniene, Vita
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 121 - 121
  • [49] Dendritic cells in pancreatic cancer immunotherapy: Vaccines and combination immunotherapies
    Yang, Jia
    Shangguan, Junjie
    Eresen, Aydin
    Li, Yu
    Wang, Jian
    Zhang, Zhuoli
    PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (12)
  • [50] Dendritic cell immunotherapy for breast cancer
    Pinzon-Charry, Alberto
    Schmidt, Chris
    Lopez, Jose Alejandro
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2006, 6 (06) : 591 - 604
12345